World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
120
Citations
84525
World Ranking
255
National Ranking
149

John Blenis publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where John Blenis sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 261 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

John Blenis D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where John Blenis sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 120 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

John Blenis is a researcher affiliated with Cornell University in the United States. Their primary field of study lies within Biochemistry, Genetics, and Molecular Biology, with a significant focus on Molecular Biology. Other notable subfields in their research include Cancer Research, Cell Biology, Physiology, and Epidemiology.

The main topics covered in John Blenis's work include Cancer, Hypoxia, and Metabolism; RNA modifications and cancer; PI3K/AKT/mTOR signaling in cancer; Epigenetics and DNA Methylation; Autophagy in Disease and Therapy; Calcium signaling and nucleotide metabolism; and Metabolomics and Mass Spectrometry Studies.

John Blenis's publication record features contributions to several journals and venues, with multiple papers published in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Cell
  • Cancer Research
  • Nature
  • Cell

Frequent co-authors in John Blenis's research collaborations include:

  • Lewis C. Cantley
  • Vivien Low
  • Noah Dephoure
  • Sungyun Cho
  • Gina Lee

Some of the recent published papers by John Blenis are:

  • "An atlas of substrate specificities for the human serine/threonine kinome," 2023, Nature
  • "Age-induced accumulation of methylmalonic acid promotes tumour progression," 2020, Nature
  • "mTORC1 promotes cell growth via m6A-dependent mRNA degradation," 2021, Molecular Cell
  • "The intrinsic substrate specificity of the human tyrosine kinome," 2024, Nature
  • "Altered propionate metabolism contributes to tumour progression and aggressiveness," 2022, Nature Metabolism

Best Publications

  • Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

    Anne Brunet;Azad Bonni;Michael J Zigmond;Michael Z Lin

  • ERK AND P38 MAPK-ACTIVATED PROTEIN KINASES: A FAMILY OF PROTEIN KINASES WITH DIVERSE BIOLOGICAL FUNCTIONS

    Philippe P. Roux;John Blenis

  • Molecular mechanisms of mTOR-mediated translational control

    Xiaoju Max Ma;John Blenis

  • The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

    Michelle C. Mendoza;E. Emrah Er;John Blenis

  • Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

    Brendan D Manning;Brendan D Manning;Andrew R Tee;M.Nicole Logsdon;John Blenis

  • Signal transduction via the MAP kinases: proceed at your own RSK.

    John Blenis

  • Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

    Diane C Fingar;John Blenis

  • Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.

    Haiying Zhang;Daniela Freitas;Han Sang Kim;Han Sang Kim;Kristina Fabijanic

  • Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

    Andrew R Tee;Brendan D Manning;Brendan D Manning;Philippe P Roux;Lewis C Cantley;Lewis C Cantley

  • Nuclear localization and regulation of erk- and rsk-encoded protein kinases.

    Rey-Huei Chen;C. Sarnecki;J. Blenis

  • Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.

    Jongkyeong Chung;Calvin J. Kuo;Gerald R. Crabtree;John Blenis

  • Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.

    B Cheatham;C J Vlahos;L Cheatham;L Wang

  • mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events

    Marina K. Holz;Bryan A. Ballif;Steven P. Gygi;John Blenis

  • Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

    Diane C. Fingar;Sofie Salama;Christina Tsou;Ed Harlow

  • Rapamycin: one drug, many effects

    Jing Li;Sang Gyun Kim;John Blenis

  • Molecular interpretation of ERK signal duration by immediate early gene products

    Leon O. Murphy;Sallie Smith;Rey Huei Chen;Diane C. Fingar

  • ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK

    Kenneth W. Wood;Charlyn Sarnecki;Thomas M. Roberts;John Blenis

  • mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.

    Diane C. Fingar;Celeste J. Richardson;Andrew R. Tee;Lynn Cheatham

  • Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-Fos

    Sudhanshu Agrawal;Anshu Agrawal;Barbara Doughty;Andrew Gerwitz

  • Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

    Andrew R. Tee;Diane C. Fingar;Brendan D. Manning;David J. Kwiatkowski

Frequent Co-Authors

Lewis C. Cantley
Lewis C. Cantley Harvard University
Philippe P. Roux
Philippe P. Roux University of Montreal
Steven P. Gygi
Steven P. Gygi Harvard University
Jongkyeong Chung
Jongkyeong Chung Seoul National University
Bryan A. Ballif
Bryan A. Ballif University of Vermont
Raymond L. Erikson
Raymond L. Erikson Harvard University
John M. Asara
John M. Asara Beth Israel Deaconess Medical Center
Elizabeth P. Henske
Elizabeth P. Henske Harvard Medical School
Brendan D. Manning
Brendan D. Manning Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Molecular Biology often explore other health-focused career paths that intersect with human behavior, genetics, and clinical sciences. There are diverse online degree options that complement a background in molecular biology and broaden career opportunities.

For those drawn to the mental health sector, online clinical mental health counseling programs offer flexible study options and can lead to licensure and practice in various settings. Similarly, online programs in counseling frequently include specialized tracks. For budget-conscious students, discovering the cheapest masters in counseling ensures quality education without a heavy financial burden.

There’s also growing interest in child-focused mental health, with online masters child psychology programs offering in-depth understanding of developmental and behavioral issues among youth.

Alternatively, those curious about the intersection of biology, behavior, and law may consider a degree in forensic psychology. Learning how much do forensic psychologists make can offer insight into the financial prospects in this field.

Each of these online degrees provides targeted skills and unique career trajectories, making them worthwhile considerations for molecular biology students looking to diversify or specialize further.

Best Scientists Citing John Blenis

Trending Scientists

Recently Published Articles